These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2207913)

  • 1. Detecting and treating dyslipoproteinemias.
    Horlick L
    CMAJ; 1990 Oct; 143(7):607-9. PubMed ID: 2207913
    [No Abstract]   [Full Text] [Related]  

  • 2. Standard lipid profile.
    Tiyyagura SR; Smith DA
    Clin Lab Med; 2006 Dec; 26(4):707-32. PubMed ID: 17110236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New results of studies of plasma lipoprotein metabolism and the pathogenesis of hyperlipoproteinemias].
    Szollár L
    Orv Hetil; 1984 Oct; 125(43):2599-609. PubMed ID: 6493768
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of serum cholesterol/triglyceride ratio to discern for which individuals the Friedewald formula can be used confidently.
    González Estrada M; Rodríguez Ferrer CR; Astarloa IR; Lahera EM
    Clin Chem; 1990 Sep; 36(9):1673-5. PubMed ID: 2208709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physical activity and dyslipoproteinemia].
    König D; Deibert P; Dickhuth HH; Berg A
    MMW Fortschr Med; 2004 Jul; 146(27-28):34-7. PubMed ID: 15526660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and treatment of lipid disorders].
    Assmann G; Davignon J; Fernández-Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
    Rev Clin Esp; 1988 Nov; 183(8):433-41. PubMed ID: 3222514
    [No Abstract]   [Full Text] [Related]  

  • 7. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible dyslipoproteinemia in patients with malaria is associated with a shortened prostaglandin I2 half-life in plasma.
    Efthimiou Y; Pirich C; Stomatopoulos J; O'Grady J; Sinzinger H
    Wien Klin Wochenschr; 1992; 104(22):705-6. PubMed ID: 1475977
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum lipid and lipoprotein levels in populations of Beijing].
    Li JZ
    Zhonghua Yi Xue Za Zhi; 1988 Jun; 68(6):327-31, 24. PubMed ID: 3228725
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nutritional therapy in disorders of lipid metabolism].
    Wolfram G
    Internist (Berl); 1992 Jan; 33(1):38-43. PubMed ID: 1551762
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in lipid metabolism in pregnancy in relation to gestoses].
    Meincke H; Kopietz K
    Zentralbl Gynakol; 1986; 108(8):511-3. PubMed ID: 3727851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipoproteinemias after heart and heart-lung transplantation: potential relation to accelerated graft arteriosclerosis.
    Bilodeau M; Fitchett DH; Guerraty A; Sniderman AD
    J Heart Transplant; 1989; 8(6):454-9. PubMed ID: 2614546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipoproteinemias in industrial workers: relationship with hypertension and overweight.
    Vangelova K; Deyanov C
    Cent Eur J Public Health; 2000 May; 8(2):77-9. PubMed ID: 10857042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hyperlipoproteinemia by plasma exchange].
    Homma Y
    Nihon Rinsho; 1992 Jan; 50 Suppl():370-3. PubMed ID: 1578709
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidental finding: increased cholesterol level].
    Parhofer K
    MMW Fortschr Med; 2010 Aug; 152(31-33):30-2. PubMed ID: 20828065
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
    Saitta A; Bonaiuto M; Lanzafame F; Mileto A; Pernice F; Cinquegrani M; Mazza G; Micali G; Pangallo A; Fodale P
    Clin Ter; 1988 Mar; 124(5):373-81. PubMed ID: 2974348
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specificity and sensitivity of lipoprotein lipids in normal persons and cardiovascular patients].
    Herrmann W; Biermann J
    Z Gesamte Inn Med; 1985 Mar; 40(6):180-3. PubMed ID: 4002758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of hyperlipoproteinemia].
    Drexel H; Follath F
    Schweiz Rundsch Med Prax; 1993 Apr; 82(17):506-9. PubMed ID: 8493437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level.
    Pados G; Kusztos D; Németh-Csóka M; Valyon M; Farkas K
    Ther Hung; 1983; 31(2):59-61. PubMed ID: 6571183
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hyperlipoproteinemia in the production of atherosclerosis. Risk factors: diagnosis and treatment].
    Pedraza A
    Rev Fac Cien Med Univ Nac Cordoba; 1993; 51(1):21-33. PubMed ID: 7809452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.